Urdu Translation of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children
Urdu Translation of Psychometric Properties Analysis of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children
Riphah International University
80 participants
May 12, 2025
OBSERVATIONAL
Conditions
Summary
The ability to move with ease is labelled as mobility. Limitations in mobility are frequent, recovery of these skills is crucial for physical performance which gives children valuable social possibilities and has long-term advantages for their physical and mental health. The high-level mobility assessment tool (HiMAT) is a unidimensional performance to measure the degree of high-level mobility in traumatic brain injury patients. The revised HiMAT has been utilised recently in paediatric populations to assess clinical trial outcomes and measure high-level motor skills. Urdu translation of revised HiMAT will be executed by using forward backwards translation method. Two bilingual translators fluent in both Urdu and English languages will facilitate the researcher in the translation of the tool. This final translated version will be then tested for validity and reliability on all participants of the study. The psychometric properties of the tool will be assessed including reliability, internal consistency, and item discrimination.
Eligibility
Inclusion Criteria4
- Children with age group 5-12 years
- No condition affecting mobility of children
- Able to understand and follow instruction.
- Can speak \& understand language
Exclusion Criteria7
- Children with visual impairments.
- Children with conditions affecting their mobility.
- Children with any history of surgery in the past one year.
- Children with any cardiorespiratory comorbidities.
- Children with muscle strain, ligament sprain or joint laxity in lower extremities.
- Cognition less than 20 on Mini Mental State Examination (MMSE).
- Children with any history of any foot deformity
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06986720